Cogent Biosciences, Inc.
COGT
Revenue
0.00
0.000.00%
-Assets
429.94M
▼-46.18M▼-9.70%
3 Months ChangeLiabilities
56.71M
▲2.94M▲5.46%
3 Months ChangeFree Cash Flow
-52.60M
▼-11.98M▼-29.49%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-03
Form 8-K
ID: 0001193125-24-211584
2024-08-06
Form 10-Q
ID: 0000950170-24-091229
2024-08-06
Form 8-K
ID: 0000950170-24-091220
2024-06-27
Form 8-K
ID: 0001193125-24-169756
2024-06-05
Form 8-K
ID: 0001193125-24-155116
2024-05-07
Form 10-Q
ID: 0000950170-24-053977
2024-05-07
Form 8-K
ID: 0000950170-24-053974
2024-03-22
Form 8-K
ID: 0001193125-24-074628
2024-02-26
Form 8-K
ID: 0000950170-24-019754
2024-02-14
Form 8-K
ID: 0001193125-24-035203